For 22 years, Jason Mazzola’s life was defined by a genetic condition that can cause autism and intellectual disability. Then he started taking an experimental drug.

Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.